- Home
- EOD vs CDTX Comparison
EOD vs CDTX Comparison
Compare EOD & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOD
- CDTX
- Stock Information
- Founded
- EOD 2007
- CDTX 2012
- Country
- EOD United States
- CDTX United States
- Employees
- EOD N/A
- CDTX N/A
- Industry
- EOD Investment Managers
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EOD Finance
- CDTX Health Care
- Exchange
- EOD Nasdaq
- CDTX Nasdaq
- Market Cap
- EOD 214.9M
- CDTX 229.0M
- IPO Year
- EOD N/A
- CDTX 2015
- Fundamental
- Price
- EOD $4.99
- CDTX $21.70
- Analyst Decision
- EOD
- CDTX Strong Buy
- Analyst Count
- EOD 0
- CDTX 6
- Target Price
- EOD N/A
- CDTX $32.20
- AVG Volume (30 Days)
- EOD 118.1K
- CDTX 127.4K
- Earning Date
- EOD 01-01-0001
- CDTX 11-07-2024
- Dividend Yield
- EOD 9.28%
- CDTX N/A
- EPS Growth
- EOD N/A
- CDTX N/A
- EPS
- EOD N/A
- CDTX N/A
- Revenue
- EOD N/A
- CDTX $44,653,000.00
- Revenue This Year
- EOD N/A
- CDTX N/A
- Revenue Next Year
- EOD N/A
- CDTX N/A
- P/E Ratio
- EOD N/A
- CDTX N/A
- Revenue Growth
- EOD N/A
- CDTX 44.48
- 52 Week Low
- EOD $3.73
- CDTX $10.00
- 52 Week High
- EOD $4.71
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- EOD 57.71
- CDTX 46.63
- Support Level
- EOD $4.77
- CDTX $19.87
- Resistance Level
- EOD $4.93
- CDTX $27.70
- Average True Range (ATR)
- EOD 0.08
- CDTX 2.33
- MACD
- EOD 0.01
- CDTX -0.79
- Stochastic Oscillator
- EOD 85.19
- CDTX 21.40
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.